Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gluten Degrading Enzymes for Treatment of Celiac Disease.

Nutrients - 15 Jul 2020

Wei Guoxian, Helmerhorst Eva J, Darwish Ghassan, Blumenkranz Gabriel, Schuppan Detlef

Abstract excerpt

Celiac disease (CeD) affects about 1% of most world populations. It presents a wide spectrum of clinical manifestations, ranging from minor symptoms to mild or severe malabsorption, and it may be associated with a wide variety of autoimmune diseases. CeD is triggered and maintained by the ingestion of gluten proteins from wheat and related grains. Gluten peptides that resist gastrointestinal digestion are...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoimmunity
Share to Celiac Disease
Share to Diet, Gluten-Free

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Enzyme Stability

Share to Glutens

Share to HLA-DQ Antigens

Share to Proteolysis

Share to Subtilisins

Source

Open in PubMed Open full text

Identifiers

PMID: 32679754
DOI: 10.3390/nu12072095
PMCID: PMC7400306

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gluten Degrading Enzymes for Treatment of Celiac Disease.PMID 32679754Read ↗

Next-generation therapies for celiac disease: The gluten-targeted approachesSemantic proximity Read ↗

A new microbial gluten-degrading prolyl endopeptidase: Potential application in celiac disease to reduce gluten immunogenic peptidesSemantic proximity Read ↗

Co-factors, Microbes, and Immunogenetics in Celiac Disease to Guide Novel Approaches for Diagnosis and Treatment.Semantic proximity Read ↗

Rationally engineered prolyl endopeptidases from Sphingomonas capsulata with improved hydrolytic activity towards pathogenic peptides of celiac diseases.Semantic proximity Read ↗

Molecular and in vivo studies of a glutamate-class prolyl-endopeptidase for coeliac disease therapySemantic proximity Read ↗

Emerging Pharmaceutical Therapies to Address the Inadequacy of Gluten-Free Diet for Celiac DiseaseSemantic proximity Read ↗

Celiac Disease—New Insights in Pathogenesis, Diagnosis and ManagementSemantic proximity Read ↗

Sequence and Structural Analysis of human gut microbial Prolyl Oligopeptidases (POPs): towards design of therapeutics for Celiac DiseaseSemantic proximity Read ↗

Celiac disease: from pathogenesis to novel therapies.Semantic proximity Read ↗

Advances in understanding the potential therapeutic applications of gut microbiota and probiotic mediated therapies in celiac disease.Semantic proximity Read ↗

Beyond the gluten-free diet: Innovations in celiac disease therapeutics.Semantic proximity Read ↗

Against the grain: an overview of celiac disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.